Flexicare Acquires Clement Clarke International
20th June 2023
We are pleased to announce that on the 31st May 2023, Flexicare completed its acquisition of Clement Clarke International (CCI), a UK based medical devices manufacturer with over 100 years of history.
With devices such as its Peak Flow Meter recognised in the industry as “The Gold Standard” for Expiratory Flow Measurement, CCI has also forged strong relationships with leading pharmaceutical companies to deliver patient solutions that support correct inhaler use and technique.
Hash Poormand, Managing Director of Flexicare adds “We are excited to put plans in motion to continue investing in CCI’s portfolio development and expand on its heritage of diagnosis, monitoring and treatment of respiratory conditions.”
The news follows the recent Flexicare rebrand announcement and launch of a new immersive website, which includes the Clement Clarke product portfolio of Inhaler Training Technique devices.
Flexicare Group continues to expand and diversify its portfolio, building on its recent acquisitions of Medisize, WyMedical and Neoforce.
With over 40 years of experience, Flexicare has supported clinicians worldwide to enhance patient outcomes with class leading innovative devices.
Flexicare is a leading designer and global provider of innovative medical devices.
Headquartered in the UK, our global network of 17 subsidiaries supports over 105 countries with dedicated in-market clinical experts and customer service centres.